⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 18, 2025Open Access

Supplementary Figure S8 from Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance

Kenichi Suda Yukihiro Yoshida Hidenori Sato Shuta Ohara Akira Hamada Masaya Yotsukura Kouya Shiraishi Ryuji Hamamoto Yasutaka Chiba Takashi Kohno Yasushi Yatabe Shun‐ichi Watanabe Yasuhiro Tsutani Tetsuya Mitsudomi

View Full Paper

Ask AI

Bookmark

Share

Key Points

To determine the prognostic significance of OLFM1 and BMP6 in early-stage nonsquamous NSCLC.
Analysis of OLFM1 and BMP6 expression levels in the TCGA cohort.
Evaluation of prognostic implications using the Human Protein Atlas.
Identified OLFM1 and BMP6 as key prognostic factors for recurrence in early-stage NSCLC.
Data supports their potential role in treatment decisions and patient monitoring.

Implication

Prognostic analysis indicates OLFM1 and BMP6 impact recurrence in early-stage nonsquamous NSCLC, highlighting clinical relevance.

Abstract

Figure S8. Prognostic implications of BMP6 and OLFM1 in TCGA variation cohort in the Human Protein Atlas.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Suda et al. (2025) studied this question.

synapsesocial.com/papers/69449a922f0218eca950877b https://doi.org/10.1158/2767-9764.30908579

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S9 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
2Supplementary Figure S10 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
3Supplementary Figure S11 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
4Supplementary Figure S6 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
5Supplementary Figure S3 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025

Supplementary Figure S5 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
Table 2 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
Supplementary Figure S1 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025